Basaglar is administered subcutaneously, usually in the abdomen, thigh, or upper arm. It is administered once a day, but the specific time and dosage will depend on the individual needs of the patient and will be prescribed by the doctor.

Injection Instructions

Check your insulin: Make sure that the insulin is clear and colorless. Basaglar should never be cloudy or discolored.

Prepare injection: Use a prefilled insulin pen or syringe as prescribed. If using a pen, remove the cap and check the insulin cartridge.

Clean injection site: Use an alcohol wipe to clean the skin at the site of injection.

Inject the insulin: Insert the needle at a 90-degree angle into the skin and push the plunger to inject the dose. Hold the needle in place for about 5-10 seconds to ensure that the full dose is delivered.

Basaglar works by delivering insulin glargine, a long-acting insulin that has a slow, steady release into the bloodstream. It works by:

Binding to insulin receptors on the surface of cells, allowing glucose to be taken up from the bloodstream into cells.

Suppressing the production of glucose by the liver, helping to reduce the amount of sugar released into the bloodstream.

Lowering blood glucose levels: Basaglar helps control blood sugar levels throughout the day and night, providing basal insulin coverage (constant insulin release) and mimicking the body’s natural insulin release.

The insulin in Basaglar is absorbed slowly from the injection site, providing a steady and consistent effect for up to 24 hours. Therefore, it causes less fluctuation in blood glucose levels than short-acting insulins, which work very fast and have a marked peak effect.

Like other drugs, Basaglar may cause side effects. The common side effects include

Hypoglycemia, Low Blood Sugar: The most frequent side effect of insulin treatment is low blood sugar that is caused when the insulin dosage is higher than what food intake was or high bodily activity. Signs of hypoglycemia may manifest as shaking, dizziness, sweating, and even confusion or unconsciousness at worst.

Injection site reaction: includes redness, swelling, or itchy sensation at the injection site.

Weight Gain: Some individuals might gain weight due to the use of insulin.

Edema (Swelling): Hands, feet, or ankles might swell in some people.

Allergic Reactions: Although rare, allergic reactions to insulin, including Basaglar, may be possible. Symptoms may include rash, itching, or breathing difficulty. In severe cases, anaphylaxis, a life-threatening allergic reaction, might occur.

Lipodystrophy: Repeated injections of insulin in the same area can lead to alteration in the fatty tissue under the skin, and this leads to lipodystrophy, which causes lumps or indentations.

Hypoglycemia: As with all insulins, Basaglar can cause hypoglycemia, especially if the dose is too high. Monitoring blood sugar levels closely and recognizing signs of low blood sugar should be treated promptly.

Dosing Adjustments: The Basaglar dosage should be changed in patients whose diet or exercise has changed, or in those who have illness, leading to a change in their blood sugar level.

Kidney or Liver Disease: Basaglar may need dosage adjustment in patients with kidney or liver diseases. Use of Basaglar should be approached with caution in the presence of kidney or liver disease.

Pregnancy and Breastfeeding: Basaglar is usually safe to use during pregnancy and breastfeeding, but the dose should be adjusted. A patient should always consult a health care provider about the use of insulin during pregnancy.

1. Oral Antidiabetic Medications: When used in combination with oral antidiabetic drugs such as sulfonylureas or metformin, Basaglar may enhance the blood sugar-lowering effects, potentially leading to an increased risk of hypoglycemia. Regular blood sugar monitoring is essential to adjust the dosage accordingly.
2. Beta-blockers: Beta-blockers (e.g., propranolol) may mask the symptoms of hypoglycemia, such as shaking or rapid heartbeat, while using Basaglar. This could make it harder to detect low blood sugar, so blood glucose should be monitored closely.
3. Corticosteroids: Medications like corticosteroids (e.g., prednisone) can increase blood sugar levels, potentially counteracting the effects of Basaglar. Adjustments in insulin dosage may be needed when corticosteroids are used.
4. Diuretics: Thiazide diuretics (e.g., hydrochlorothiazide) can raise blood sugar levels, which may require changes in Basaglar’s dosage. Close monitoring of blood glucose is advised when both medications are used together.

Type 1 Diabetes: Basaglar is usually taken once daily as a basal insulin to control blood sugar. It is often used along with rapid-acting insulin at meals to manage blood sugar at meals.

Type 2 Diabetes: Basaglar is typically administered once daily as a basal insulin in patients who are not controlled with oral medications or other injectables, including non-insulin injections.

Starting Dose: The starting dose will depend on the patient’s individual needs, current blood sugar levels, and insulin sensitivity. Typical starting doses range from 10 units to 20 units per day.

Basaglar is a prescription medication and must be prescribed by a healthcare provider. People with diabetes should work with their doctor to determine the appropriate insulin regimen, monitor blood glucose levels regularly, and adjust the dose as needed. Basaglar should not be used without medical supervision, and it is important to follow the healthcare provider’s recommendations closely.

1. What is Basaglar?

   • Basaglar is an insulin glargine injection used to help control blood sugar levels in adults and children with diabetes mellitus.

2. How does Basaglar work?

   • Basaglar is a long-acting insulin that mimics the body’s natural insulin release, providing a steady level of insulin to help lower blood glucose levels throughout the day and night.

3. Who is Basaglar intended for?

   • Basaglar is intended for adults and children with type 1 or type 2 diabetes who require insulin for blood sugar control.

4. How is Basaglar administered?

   • Basaglar is administered subcutaneously (under the skin) typically once daily, at the same time each day, as directed by a healthcare provider.

5. What are the common side effects of Basaglar?

   • Common side effects may include low blood sugar (hypoglycemia), injection site reactions, weight gain, and allergic reactions. Always report any unusual or severe side effects to your doctor.

6. What should I do if I miss a dose of Basaglar?

   • If you miss a dose, take it as soon as you remember, unless it’s almost time for your next dose. Do not double the dose to make up for the missed one.

7. Can Basaglar be used with other diabetes medications?

   • Yes, Basaglar can be used in combination with other diabetes medications. It’s essential to follow your healthcare provider’s recommendations regarding medication combinations.

8. Is Basaglar suitable for pregnant or breastfeeding women?

   • Pregnant or breastfeeding women should discuss their options with a healthcare provider, as insulin needs may change during pregnancy and breastfeeding.

9. How should Basaglar be stored?

   • Unopened Basaglar vials or pens should be stored in the refrigerator (36°F to 46°F). Once in use, Basaglar can be kept at room temperature (up to 86°F) for up to 28 days.

10. Are there any contraindications for using Basaglar?

    • Basaglar should not be used in patients with severe low blood sugar (hypoglycemia), hypersensitivity to insulin glargine, or diabetic ketoacidosis.

11. What should I do if I experience hypoglycemia while using Basaglar?

    • If you experience symptoms of hypoglycemia (like sweating, shakiness, or confusion), consume fast-acting carbohydrates (like glucose tablets or juice) and monitor your blood sugar levels closely.

12. Can Basaglar be injected into any part of the body?

    • Basaglar injections are typically administered in the abdomen, thigh, or upper arm. Rotate injection sites to reduce the risk of lipodystrophy (fat changes) at the injection site.

13. Can you mix Basaglar with other insulins?

    • Basaglar should not be mixed with other insulins or injectable medications. Administer them in separate injections as directed by your healthcare provider.

14. How long does Basaglar last in the body?

    • Basaglar provides a continuous release of insulin for up to 24 hours, helping to maintain stable blood glucose levels.

15. What should I do if my blood sugar is too high?

    • If your blood sugar is high, consult your healthcare provider for guidance on adjusting your Basaglar dose or other aspects of your diabetes management plan.

16. Can Basaglar cause weight gain?

    • Some patients may experience weight gain while using Basaglar, which is common with insulin therapy. Maintaining a healthy diet and exercise routine can help manage this effect.

17. Is there a risk of injection site reactions with Basaglar?

    • Yes, some patients may experience redness, itching, or swelling at the injection site. Rotate injection sites to minimize these reactions.

18. Can I share my Basaglar pen with someone else?

    • No, sharing insulin pens can lead to contamination and infection. Each pen is for single-patient use only.

19. Is Basaglar available in different strengths?

    • Yes, Basaglar is available in a concentration of 100 units/mL and is provided in multi-dose pen formats for ease of use.

20. Where can I find more information about Basaglar?

    • For more information, consult your healthcare provider or pharmacist, and refer to the official Basaglar product information available from the manufacturer.